Labiotech.eu

News and Trends 23 Apr 2015

Lab equipment (finally) affordable?

Whether you are an industry giant, university laboratory or startup company, there is no way around it! Obviously your equipment budget represents a necessity… Your wallet, however, suffers the most from these expensive supplies. Imagine being able to buy good and reliable supplies at prices well below market standards. Well, this dream has now become […]

April 23, 2015 - 2 minutesmins - By Alexandre Lowrey

News and Trends 22 Apr 2015

Vaccines against Parasites, on the Horizon with XstalBio

XstalBio has commenced work on an €9.3M EU Funded Horizon 2020 project to develop vaccines that protect cattle, sheep and poultry, against infection by parasites. The 4 year “PARAGONE” collaboration involves 17 partners from Europe, Uruguay and China and will aim to move several candidate vaccines from the laboratory into practical field trials. XstalBio, as […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

OncoBEAM blood test arrives to Europe

Sysmex Inostics have signed an exclusive distributor agreement with IndivuTest, and its parent company Indivumed, a cancer research company focused on the development of individualized cancer diagnostics and therapies. This collaboration will offer Sysmex’s OncoBEAM services throughout Germany, Austria and Switzerland. IndivuTest will be responsible for commercial and sample logistics, with all testing being performed […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

Kineta and researchers from the University of Groningen, Netherlands, announced new data from a study that showed dalazatide (formerly ShK-186) is effective in immunomodulating the cells causing inflammation and damage of small blood vessels in various organs in samples from patients with Granulomatosis with Polyangiitis (GPA). The data were presented at the 17th International ANCA […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

Erytech Strengthens its Intellectual Property Position in the US

Erytech strengthed its intellectual property portfolio in the United States with the granting of a new patent and the further extension of the patent term of its core process patent. The French biopharmaceutical company develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs. The patent entitled “Medicament for […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

[Interview] Smartbone, using bioengineering to repair your bones!

Orthobiology is a field of biomedical technology, which develops new devices and products for skeletal regenerative medicine. IBI sa (Industrie Biomediche Insubri sa) is a Swiss-based company excelling in this field. I met Giuseppe Perale, co-founder and President of the company, who not only gave me the big picture on this field, but also on […]

April 22, 2015 - 5 minutesmins - By Joachim Eeckhout

News and Trends 21 Apr 2015

GATC backs Molecular Health’s tumour profiling system

GATC Biotech has signed a commercial agreement with Molecular Health to market and support Molecular Health’s state-of-the-art system for tumour profiling. Under this agreement, GATC Biotech will make the company’s analytical software, TreatmentMAP, available to patients worldwide. Every cancer is unique, which is why cancer patients respond differently to cancer treatments. Scientific discoveries and technological […]

April 21, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 21 Apr 2015

Annette Clancy joins Lysogene’s Board of Directors

Annette Clancy has been appointed Chair of the Board of Directors of Lysogene, a leading clinical-stage company focused on gene therapy to treat Central Nervous System (CNS) disorders. Ms. Karen Aiach, Founder and CEO of Lysogene, who has led Lysogene in translating its rAAVrh10 lead product for Sanfilippo from bench to bedside in an unprecedented fashion, stated: […]

April 21, 2015 - 2 minutesmins - By Lourdes Riquelme

ADN Que sont les Biotechnologies 1213x418

News and Trends 20 Apr 2015

So, what is actually Biotech?

Biotechnology is a broad domain, which includes numerous areas such as healing, feeding and fueling the world. Historically-speaking, the biotech sector started in the 80s with the discovery of gene cloning. The first “Biotech” ever born was Genentech (contraction of Gene and Technology), founded in South San Francisco, which successfully produced human insulin in bacteria. The Organisation […]

April 20, 2015 - 4 minutesmins - By Nicolas Sainte-Foie

News and Trends 18 Apr 2015

Another Partnership between Immunocore and MedImmune against Skin Cancer

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases, and MedImmune, the global biologics research and development arm of AstraZeneca have just entered into a second effective collaboration for a potential skin cancer treatment. It concerns melanoma which is a form of skin cancer that accounts for less than five per cent of […]

April 18, 2015 - 2 minutesmins - By Julie Lellouche

TEVA Eagle Pharmaceuticals leukemia bendamustine

News and Trends 17 Apr 2015

Teva took the first step to get the approval of its new leukemia treatment

FDA accepted Teva Pharma’s New Drug Application (NDA) for a liquid bendamustine hydrochloride (HCl) rapid infusion product. The drug, developed with Eagle Pharmaceuticals is now waiting for the Prescription Drug User Fee Act (PDUFA), which is expected for December 2015. In the meantime, the Israeli company remains unstoppable after a great begining of the month on […]

April 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 17 Apr 2015

Merck Serono bets on Oncology with the appointment of Dr. Alise Reicin

Merck Serono appointed Dr. Alise Reicin as Senior Vice President, Head of Global Clinical Development. The appointment is yet another example of Merck’s clear interest in oncology and immunology, two fields in which Dr. Reicin expertised. Dr. Reicin will also bring extensive research and early/late clinical development expertise to Merck Serono. In her role as […]

April 17, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lab equipment (finally) affordable?

Vaccines against Parasites, on the Horizon with XstalBio

OncoBEAM blood test arrives to Europe

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

Erytech Strengthens its Intellectual Property Position in the US

[Interview] Smartbone, using bioengineering to repair your bones!

GATC backs Molecular Health’s tumour profiling system

Annette Clancy joins Lysogene’s Board of Directors

So, what is actually Biotech?

Another Partnership between Immunocore and MedImmune against Skin Cancer

Teva took the first step to get the approval of its new leukemia treatment

Merck Serono bets on Oncology with the appointment of Dr. Alise Reicin

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!